MyoKardia

MyoKardia is dedicated to revolutionizing the treatment of cardiovascular disease. The company's first programs include hypertrophic and dilated cardiomyopathy (HCM and DCM), which together afflict approximately 1 million people in the United States, and for which no novel therapeutics have been brought to market in over a decade.

Scholarships

There are no scholarships at this time

 Events

There are no events at this time

Company Data on MyoKardia
provided by Owler


 

MyoKardia is hiring for these positions

Show me: All available jobs
loading